
An interim review of a clinical trial in South Africa showed the vaccine had virtually no impact on infection rates.
Learn more about this story at
Find more videos like this at
Follow Newsy on Facebook:
Follow Newsy on Twitter:
source
Learn more about this story at
Find more videos like this at
Follow Newsy on Facebook:
Follow Newsy on Twitter:
source